Windtree Therapeutics Inc

-0.01 (-4.34%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)8.75M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.05 Million
Adjusted EPS-$0.26
See more estimates
10-Day MA$0.34
50-Day MA$0.40
200-Day MA$0.82
See more pivots

Windtree Therapeutics Inc Stock, NASDAQ:WINT

2600 Kelly Road, Suite 100, Warrington, Pennsylvania 18976-3622
United States of America
Phone: +1.215.488.9300
Number of Employees: 33


Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company engaged in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. It focuses on the treatment of acute cardiovascular and acute pulmonary diseases. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.